The introduction to and inspiration from FDA Guidance: alternative procedures for the manufacture of cold-stored platelets intended for the treatment of active bleeding when conventional platelets are not available or their use is not practical
Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 11
Abstract
U.S. Food and Drug Administration recently issued a guidance on alternative procedures for the manufacture of cold-stored platelets intended for the treatment of active bleeding when conventional platelets are not available or their use is not practical. It was allowed to use platelets stored at 1 ℃ to 6 ℃, with a storage period of up to 14 days from the date of collection.The validation and quality monitoring of platelet manufacture retained pH items testing at the end of the storage, and platelet count and actual plasma volume testing items were not required. The guidance provided the recommendations and considerations for the manufacture, labeling, storage, transportation, bacterial contamination control, process validation, and quality monitoring sampling of cold-stored platelets, as well as the further research needs for its efficacy, particularly when conventional platelets are available and their use is practical. The scientific and regulatory considerations on cold-stored platelets in the guidance would be informative and instructive to the development of blood regulation and standards related with urgent transfusion in China.
Authors and Affiliations
Hongjie WANG, Yongjian GUO
Keywords
Related Articles
- EP ID EP738706
- DOI 10.13303/j.cjbt.issn.1004-549x.2023.11.026
- Views 3
- Downloads 0
Characteristics of HBcrAg in HBsAg-/HBV DNA+ blood donors in Wuxi area
Objective To analyze the detection characteristics of a novel serum marker, hepatitis B core-associated antigen (HBcrAg), in the HBsAg-/HBV DNA+ blood donors in Wuxi. Methods A total of 37 previous HBsAg-/HBV DNA+ blood...
Analysis of confidential unit exclusion status of voluntary blood donors in Hefei
Objective To explore the status of confidential unit exclusion(CUE) status among voluntary blood donors in Hefei, so as to provide scientific basis for blood safety. Methods From 2012 to 2021, 57 out of the 1 158 272 vol...
Analysis of ABO system hemolytic disease of the fetus and newborn in 1 040 cases and its influencing factors
Objective To analyze ABO system hemolytic disease of the fetus and newborn (HDFN) and its influencing factors in Obstetrics Department of our hospital. Methods The blood samples of 1 040 neonates and their mothers in the...
HBV infection among blood donors from 18 domestic blood stations of prefecture-level cities
Objective To analyze the hepatitis B virus (HBV) infection data of blood donors from 18 domestic blood stations, so as to investigate the HBV infection situation of blood donors. Methods The positive rate of HBV and its...
Influence of blood donors' coagulation status in apheresis platelet aggregation in vitro
Objective To investigate whether the blood donors' coagulation status may lead to apheresis platelet aggregation in vitro. Methods Thirty blood donors with aggregation in apheresis platelets collected by AMICUS blood cel...